Loading insider details...
Beta
Latest Form 4 (Aug 21, 2026): Grant/Award of 44,964 AARD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Aardvark Therapeutics, Inc. (AARD) | Grant/Award | 44,964 | n/a |
| Jun 5, 2026 | CG Oncology, Inc. (CGON) | Grant/Award | 9,354 | n/a |
| Jun 13, 2025 | Aardvark Therapeutics, Inc. (AARD) | Grant/Award | 30,508 | n/a |
| Jun 6, 2025 | CG Oncology, Inc. (CGON) | Grant/Award | 24,165 | n/a |
| Oct 7, 2024 | CG Oncology, Inc. (CGON) | Grant/Award | 15,600 | n/a |
| Jun 9, 2023 | Finch Therapeutics Group, Inc. (FNCH) | Purchase | 5,010 | $1.4K |
| Jun 15, 2022 | Finch Therapeutics Group, Inc. (FNCH) | Grant/Award | 44,843 | n/a |
| Apr 27, 2021 | Finch Therapeutics Group, Inc. (FNCH) | Grant/Award | 23,419 | n/a |